December 2018 - First Report Managed Care

Issue 12
December 2018


Steven Baskin, PhD, explained how behavioral interventions can be used to manage migraine triggers, stressors, and psychiatric comorbidities, as well as maximize medication adherence and directly treat headache with relaxation based therapies, biofeedback, and cognitive-behavioral therapy, during a session at the 2018 Scottsdale Headache Symposium. | Read More
Despite an expansion of treatment options with biologic disease-modifying antirheumatic drugs (bDMARDS) among patients with rheumatoid arthritis (RA), researchers recently found that the cost of bDMARDs is the primary driving factor for the cost of care among these patients.  | Read More
Oftentimes out-of-pockets costs affect medication adherence, and researchers suggests patients and health care professionals (HCP) discuss costs in the treatment decision-making process. However, according to a new study, presented at 2018 ACR/ARHP Annual Meeting, researchers found that patients and HCPs do not always discuss cost unless it is addressed by patients who perceived it as “very important.”  | Read More
A population health model focused on health and wellness is the key to success in value-based care, Cary B. Shames, DO, CHCQM, ABQAURP, vice president and chief medical officer at Sharp Health Plan explained at NAMCP. | Read More